Sugaya Norio
Department of Pediatrics, Keiyu Hospital, Kanagawa, Japan.
Uirusu. 2005 Jun;55(1):111-4. doi: 10.2222/jsv.55.111.
Dramatic advances in the diagnosis and treatment of influenza in Japan has been made in recent years. Rapid diagnosis tests for influenza are routinely performed in Japanese hospitals. Both zanamivir and oseltamivir have been approved for the treatment of influenza since 2001, in addition to amantadine. Japan has the highest figure of neuraminidase inhibitor-use in the world because the treatment of influenza with neuraminidase inhibitors is covered by Japan's National Health Insurance program. Therefore, we should carefully observe the appearance of resistance strains and side effects to neuraminidase inhibitors.
近年来，日本在流感的诊断和治疗方面取得了显著进展。日本医院常规进行流感快速诊断检测。自2001年以来，除金刚烷胺外，扎那米韦和奥司他韦均已获批用于治疗流感。日本是世界上神经氨酸酶抑制剂使用量最高的国家，因为日本的国民健康保险计划涵盖了用神经氨酸酶抑制剂治疗流感。因此，我们应密切观察神经氨酸酶抑制剂耐药菌株的出现及副作用。
